Կանադա - անգլերեն - Health Canada

schering-plough canada inc - homosalate; octisalate; zinc oxide; oxybenzone; octinoxate; octocrylene - lotion - 8.0%; 5.0%; 5.0%; 5.0%; 7.5%; 5.0% - homosalate 8.0%; octisalate 5.0%; zinc oxide 5.0%; oxybenzone 5.0%; octinoxate 7.5%; octocrylene 5.0% - sunscreen agents

Կանադա - անգլերեն - Health Canada

schering-plough canada inc - homosalate; octisalate; zinc oxide; octinoxate; octocrylene - lotion - 5.0%; 5.0%; 5.0%; 7.5%; 3.0% - homosalate 5.0%; octisalate 5.0%; zinc oxide 5.0%; octinoxate 7.5%; octocrylene 3.0% - sunscreen agents

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

schering plough corporation - moxifloxacin hydrochloride (unii: c53598599t) (moxifloxacin - unii:u188xyd42p) - moxifloxacin 400 mg in 250 ml - avelox is indicated in adult patients for the treatment of community acquired pneumonia caused by susceptible isolates of streptococcus pneumoniae (including multi-drug resistant streptococcus pneumoniae [mdrsp]), haemophilus influenzae, moraxella catarrhalis, methicillin-susceptible staphylococcus aureus, klebsiella pneumoniae, mycoplasma pneumoniae, or chlamydophila pneumoniae [see clinical studies (14.3 )] . mdrsp isolates are isolates resistant to two or more of the following antibacterial drugs: penicillin (minimum inhibitory concentrations [mic] ≥ 2 mcg/ml), 2nd generation cephalosporins (for example, cefuroxime), macrolides, tetracyclines, and trimethoprim/sulfamethoxazole. avelox is indicated in adult patients for the treatment of uncomplicated skin and skin structure infections caused by susceptible isolates of methicillin-susceptible staphylococcus aureus or streptococcus pyogenes [see clinical studies (14.4 )]. avelox is indicated in adult patients for the treatment of complicated skin and ski

Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

schering-plough a division of schering-plough animal health limited - interferon alfa-2b 5 miu/ml;   - solution for injection - 5 miu/ml - active: interferon alfa-2b 5 miu/ml   excipient: albumin dibasic sodium phosphate glycine methyl hydroxybenzoate monobasic sodium phosphate monohydrate propyl hydroxybenzoate water for injection

Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

imed healthcare ltd. - mometasone furoate - nasal spray, suspension - 50 microgram(s) - mometasone - decongestants and other nasal preparations for topical use-corticosteroids - it is indicated for use in adults and children 12 years of age and older to treat the symptoms of seasonal allergic or perennial rhinitis.

Մալթա - անգլերեն - Medicines Authority

galpharm healthcare limited wrafton, braunton, north devon, ex33 2dl, united kingdom - loratadine - tablet - loratadine 10 milligram(s) - antihistamines for systemic use

Նոր Զելանդիա - անգլերեն - Ministry for Primary Industries

schering-plough animal health limited - tetanus antitoxin; clostridium perfringens type d toxoid - tetanus antitoxin 0 vaccine; clostridium perfringens type d toxoid 0 vaccine - vaccine

Նոր Զելանդիա - անգլերեն - Ministry for Primary Industries

schering-plough animal health limited - dichelobacter nodosus - dichelobacter nodosus 0 vaccine - vaccine

Նոր Զելանդիա - անգլերեն - Ministry for Primary Industries

schering-plough animal health limited - chlorhexidine digluconate (free base); glycerol - chlorhexidine digluconate (free base) 22.5 g/litre; glycerol 630 g/litre - antimicrobial

Նոր Զելանդիա - անգլերեն - Ministry for Primary Industries

schering-plough animal health limited - clostridium perfringens type d toxoid; levamisole phosphate; clostridium septicum toxoid; clostridium tetani toxoid; clostridium chauvoei toxoid/cells; clostridium novyi type b toxoid/cells - clostridium perfringens type d toxoid 0 vaccine; levamisole phosphate 100 g/litre; clostridium septicum toxoid 0 vaccine; clostridium tetani toxoid 0 vaccine; clostridium chauvoei toxoid/cells 0 vaccine; clostridium novyi type b toxoid/cells 0 vaccine - endoparasiticide